Work

Phase I-II Study of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Combination Therapy in Patients With Richter's Syndrome or Fludarabine-Refractory Chronic Lymphocytic Leukemia

Year: 2008

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.11.8513

Authors: Apostolia M. Tsimberidou, William G. Wierda, William Plunkett, Razelle Kurzrock, Susan O'Brien, Sijin Wen, Alessandra Ferrajoli, Farhad Ravandi-Kashani, Guillermo Garcia-Manero, Zeev Estrov, Thomas J. Kipps, Jennifer R. Brown, Albert Fiorentino, Susan Lerner, Hagop M. Kantarjian, Michael J. Keating

Institutions: The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Moores Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2140402067

FWCI: 7.194

Cites: 45

Cited by: 162

Related to: 10